Literature DB >> 9272913

Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.

G C Riise1, C Kjellström, W Ryd, H Scherstén, F Nilsson, G Mårtensson, B A Andersson.   

Abstract

Acute rejection of the transplanted lung is a clinical problem, since it decreases graft survival and predisposes the patient to chronic rejection and obliterative bronchiolitis (OB). In an earlier study, we had indications that eosinophil cationic protein (ECP) from activated eosinophils and hyaluronan (HYA) from fibroblasts were associated with acute pulmonary rejection. This prospective longitudinal study was designed to investigate whether molecules from activated inflammatory cells in bronchoalveolar lavage (BAL) fluid could serve as clinically useful diagnostic markers for acute rejection. BAL fluid from 138 bronchoscopies performed in 10 single lung, four bilateral lung and five heart-lung transplant recipients were analysed. Nine patients were studied for a period of more than 1 yr (mean 13.4 months) after surgery. Differential cell counts were made from the BAL fluid. ECP, myeloperoxidase (MPO), HYA and interleukin-8 (IL-8) were used as indirect markers for activation and attraction of eosinophils, neutrophils and fibroblasts, respectively. Fifty four episodes of acute rejection were diagnosed. Two patients developed OB. Nine episodes of bacterial infection, 13 episodes of cytomegalovirus (CMV) pneumonitis, three of Pneumocystis carinii infection and one of respiratory syncytial virus (RSV) infection were diagnosed. The mean levels of ECP, MPO, HYA and IL-8 were all higher during rejection episodes, but differences were not statistically significant compared to no rejection, when the confounding factors of time, concomitant infection, and repeated measures in the same individual had been accounted for. We could not confirm that measurements of eosinophil cationic protein, myeloperoxidase, hyaluronan and interleukin-8 in bronchoalveolar lavage fluid can be used as diagnostic markers for acute rejection in the postoperative follow-up of lung transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272913     DOI: 10.1183/09031936.97.10081742

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  16 in total

1.  Human neutrophil peptide in lung chronic allograft dysfunction.

Authors:  Cavan Reilly; Tereza Cervenka; Marshall I Hertz; Trisha Becker; Chris H Wendt
Journal:  Biomarkers       Date:  2011-10-11       Impact factor: 2.658

Review 2.  Lymphatic Vessels: The Next Frontier in Lung Transplant.

Authors:  Ye Cui; Kaifeng Liu; Anthony Mark Lamattina; Gary Visner; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 3.  Solving the Conundrum of Eosinophils in Alloimmunity.

Authors:  Cherie Alissa Lynch; Yizhan Guo; Zhongcheng Mei; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

4.  IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.

Authors:  M Laan; A Lindén; G C Riise
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

5.  Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.

Authors:  X Liu; Z Yue; J Yu; E Daguindau; K Kushekhar; Q Zhang; Y Ogata; P R Gafken; Y Inamoto; A Gracon; D S Wilkes; J A Hansen; S J Lee; J Y Chen; S Paczesny
Journal:  Am J Transplant       Date:  2016-03-14       Impact factor: 8.086

Review 6.  Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.

Authors:  Nicole E Speck; Macé M Schuurmans; Christian Murer; Christian Benden; Lars C Huber
Journal:  Respir Res       Date:  2016-06-21

Review 7.  Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers.

Authors:  Nicole E Speck; Macé M Schuurmans; Christian Benden; Cécile A Robinson; Lars C Huber
Journal:  Respir Res       Date:  2017-08-07

8.  Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients.

Authors:  Anna Stjärne Aspelund; Helena Hammarström; Malin Inghammar; Hillevi Larsson; Lennart Hansson; Bertil Christensson; Lisa I Påhlman
Journal:  Am J Transplant       Date:  2017-09-15       Impact factor: 8.086

9.  Bronchoalveolar lavage cytokines are of minor value to diagnose complications following lung transplantation.

Authors:  Nicole E Speck; Elisabeth Probst-Müller; Sarah R Haile; Christian Benden; Malcolm Kohler; Lars C Huber; Cécile A Robinson
Journal:  Cytokine       Date:  2019-08-07       Impact factor: 3.861

Review 10.  The Rise and Fall of Hyaluronan in Respiratory Diseases.

Authors:  Mark E Lauer; Raed A Dweik; Stavros Garantziotis; Mark A Aronica
Journal:  Int J Cell Biol       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.